Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02041559 | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | unknown | — | 1,500 | Yonsei UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02037464 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer(CAPSAICIN) | unknown | Phase 2 | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 16, 2014 |
| clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | unknown | N/A | 120 | Cancer Research UKOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002775 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 37 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003064 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 1 / Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003560 | Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 2 | 40 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003718 | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003633 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | unknown | Phase 1 | 12 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | 17 | St. Barnabas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00002477 | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer | unknown | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00021385 | Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00045123 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | unknown | Phase 2 | — | Myrexis Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01999933 | Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer | unknown | Phase 2 / Phase 3 | 600 | Mei ShiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT00002465 | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00004064 | Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | unknown | Phase 2 | 102 | AltaRexINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00005025 | Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | unknown | Phase 2 | — | John Stoddard Cancer Center at Iowa Methodist Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005939 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | unknown | Phase 1 / Phase 2 | — | Center for Molecular MedicineOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00017303 | Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer | unknown | Phase 2 | — | CytranINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00348998 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | unknown | Phase 2 | 18 | Virginia Mason Hospital/Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01470235 | Hypodontia and Ovarian Cancer | unknown | — | 200 | University of AarhusOTHER | 1 | Nov 1, 2013 | clinicaltrials |
| NCT01938105 | Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer | unknown | Phase 2 | 40 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Sep 26, 2013 | clinicaltrials |
| NCT00003733 | Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer | unknown | Phase 2 | 40 | SmithKline BeechamINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00009750 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00322114 | Lycopene in Preventing Prostate Cancer in Healthy Participants | unknown | N/A | 150 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00354497 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | unknown | Phase 2 | 800 | Lawrence Livermore National Laboratory at University of CaliforniaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00897039 | Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | unknown | — | 60 | Southeastern Gynecologic OncologyOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002487 | Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 2 | — | Ottawa Regional Cancer CentreOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00004115 | Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00274950 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | unknown | Phase 3 | 105 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00276718 | Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors | unknown | N/A | 100 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00503646 | Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners | unknown | N/A | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00363285 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | unknown | Phase 3 | 900 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00462397 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | unknown | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00632047 | Early Detection of Breast Cancer and Cervical Cancer in Women in India | unknown | Phase 2 | 151,538 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00757263 | Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00758056 | Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00758173 | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00959023 | Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer | unknown | — | 21,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 22, 2014source: clinicaltrials